Latest on Medically in Oncology
Diversifying our approach to clinical development
The innovation of current therapy towards personalised treatments poses the need to remodel clinical trials' design.
Lung cancer: new weapons against an old foe
Can new diagnostic tools deliver earlier diagnosis and smarter treatment choices?
Bladder Cancer: The Facts
Bladder cancer is one of several cancers associated with a high rate of mutations, which may be linked to a heightened immunogenicity. Learn more about the role of tumour-infiltrating immune cells and the pathways governing the immune response.
The Cancer Immunity Cycle
Read about the Cancer Immunity Cycle and how this was developed.
PD-L1/PD-1 Pathway: A Security Checkpoint
Learn more about how PD-L1/ PD-1 pathway acts as a security checkpoint in normal cells, however cancer cells are able to bypass this checkpoint by expressing PD-L1 and escaping immune detection
Cancer immunotherapy research: exploring the immune response against cancer
Cancer immunotherapy research seeks to understand how to utilize the body’s versatile defense system against cancer’s ability to evolve and evade destruction.